Encapson moves to new premises

Note for the Press

Encapson has developed Sono-Coat™; an innovative echogenic coating system to improve the ultrasound visibility of medical devices in the body. The Sono-Coat™ technology is based on a coating matrix containing acoustically reflective microspheres. The microspheres scatter the ultrasound waves in all directions. The enhanced reflection leads to crystal clear and sharp images on the ultrasound screen. The Sono-Coat™ technology platform consists of two coating systems: the M-series for needles and the P-Series for catheters.

Sono-Coat™ enables precise targeting of objects in deeper tissue structures such as liver and kidney biopsies, facilitates vascular access, setting peripheral nerve block and tip confirmation of CVC, PICC, Drainage and Regional Anaesthesia catheters. The unmatched ultrasound visibility of Sono-Coat™ supports the physician in performing accurate, safe and error-free ultrasound-guided procedures.

Encapson provides coating services to the medtech industry. We develop advanced visibility solutions for a large variety of products creating unique value for your portfolio. Our company is ISO-13485:2016 certified and delivers high-quality products that meet stringent regulatory and end-user requirements.

For more information please contact us

More News

Regulatory approval first Sono-Coat™ product

In July 2020 our undisclosed top-10 MedTech customer obtained FDA approval for a MW ablation needle with a Sono-Coat™ tip.

Sono-Coat™ core patents granted in US and EU

In May 2020 the first two Sono-Coat™ core patents were granted in Europe. Both patents were already granted in the US, China and Japan and several other countries.

Bram Pape appointed as Chief Operating Officer Encapson

Bram Pape has been appointed as Encapson’s new COO. He has succeeded Mr. Lee Ayres who was appointed Chief Technology Officer.
News overview